Orthobiologics Market size to grow by USD 2.64 billion from 2022-2027, North America to account for 41% of market growth - Technavio
NEW YORK, Dec. 1, 2023 /PRNewswire/ -- The orthobiologics market size is expected to grow by USD 2.64 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 7.88% during the forecast period, according to Technavio Research. The market is segmented by Application (Spinal fusion, Reconstructive surgery, Trauma repair, and Others), Product (Bone graft substitutes, Viscosupplementation, and Stem cells), and Geography (North America, Europe, Asia, and Rest of World (ROW)). North America is estimated to account for 41% of the market's overall growth. North America dominated the market and is expected to maintain its position during the projection period due to the presence of a well-established healthcare system that provides high-quality orthobiologics. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a PDF Sample Report
Company Profile:
Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Bioventus LLC, Globus Medical Inc., Integra Lifesciences Holdings Corp., Johnson and Johnson, Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc, Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., Xtant Medical Inc., Zimmer Biomet Holdings Inc., Arthrex Inc.
Advanced Medical Solutions Group Plc: The company offers orthobiologics solutions that include synthetic bone substitutes, collagen membranes, and bioabsorbable screws.
• To gain access to more vendor profiles available with Technavio, buy the report!
Orthobiologics Market: Segmentation Analysis
The growth of the spinal fusion segment will be significant for overall market growth during the forecast period. It is a technique that helps in permanently joining two or more vertebrae in the spine to increase stability, repair a deformity, or relieve discomfort. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
"Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio
Orthobiologics Market: Driver & Trend:
Driver
Increasing prevalence of orthopedic disorders coupled with an aging population
Increase in focus to reduce orthopedic surgeries
Rise in approvals and clearances for orthobiologics products
The increasing prevalence of orthopedic disorders coupled with an aging population drives the growth of the market. Limited physical activity and eating habits negatively influence the body's homeostasis, which worsens with age and puts most persons aged 60 and up vulnerable to orthopedic disorders such as arthritis.
Strategic alliances among market vendors are a key trend in the orthobiologics market. Identify key trends, drivers, and challenges in the market. Download a free sample report to gain access to this information.
Related Reports:
The Global Orthopedic Device Market size is estimated to grow by USD 12.11 billion between 2022 and 2027, accelerating at a CAGR of 3.85%.
The invisible orthodontics market share in North America is expected to increase to USD 1.05 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.1%.
What are the key data covered in this orthobiologics market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the orthobiologics market between 2022 and 2027.
Precise estimation of the orthobiologics market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the orthobiologics market industry across North America, Europe, Asia, and ROW
A thorough analysis of the market's competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of orthobiologics market vendors.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by Product
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/orthobiologics-market-size-to-grow-by-usd-2-64-billion-from-2022-2027--north-america-to-account-for-41-of-market-growth---technavio-302002810.html
SOURCE Technavio
